Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients (Q24245456)

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

One-year follow-up of a Brazilian randomized multicenter study comparing tacrolimus versus cyclosporine in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

A three arm study comparing immediate tacrolimus therapy with ATG induction therapy followed by either tacrolimus or cyclosporine in adult renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

One year evolution of bone mineral density in kidney transplant recipients receiving tacrolimus versus cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Analysis of primary and recurrent rejection following renal transplantation in a large, comparative, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Oral dosing of tacrolimus and cyclosporine microemulsion--results from a large multicenter study in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in kidney transplantation: twelve-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Molecular and structural consequences of early renal allograft injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Differential homocysteine levels in renal transplant patients receiving neoral versus tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Arterial hypertension in renal transplant recipients treated with tacrolimus or cyclosporine-Neoral

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression. FK506 Kidney Transplant Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

One-year glomerular filtration rate predicts graft survival in pediatric renal recipients: a randomized trial of tacrolimus vs cyclosporine microemulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Tacrolimus vs CyA Neoral in combination with MMF and steroids after cadaveric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Effects of three immunosuppressive regimens on CD4 helper function, B cell monocyte and cytokine responses in renal transplant recipients: 4-month follow-up of a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

New strategies using 'low-dose' mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Balancing benefits and harms in health care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Immunosuppressive strategies in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Problems and Limitations in Conducting Systematic Reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Late deterioration of organ transplants: a problem in injury and homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Evolution of endpoints for renal transplant outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

The natural history of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Strategies to improve long-term outcomes after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine-microemulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

How should meta-regression analyses be undertaken and interpreted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Tailoring immunosuppressive therapy for renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Tacrolimus for kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

Randomized trial comparing neoral and tacrolimus immunousuppression for recipients of renal transplants procured from different donor groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Prospective randomized study comparing FK 506 (Prograft) and cyclosporine A (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Tacrolimus/"low-dose" mycophenolate mofetil versus microemulsion cyclosporine/"low-dose" mycophenolate mofetil after kidney transplantation--1-year follow-up of a prospective, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Four-year follow-up of the European Tacrolimus Multicenter Renal Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Effect of acute rejection on expression of fibrosis associated genes in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Preliminary analysis of a randomized trial comparing microemulsion cyclosporine and tacrolimus for recipients of renal transplants from non-heart-beating donors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Assessment of the frequency and costs of posttransplantation hospitalizations in patients receiving tacrolimus versus cyclosporine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Inferior outcome of two-haplotype matched renal transplants in blacks: role of early rejection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Renal transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003961.PUB2

7 January 2021

10.1002/14651858.CD003961.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2294952

2294952

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference